atripla financial help guidelines

HIV integrase inhibitor effective for patients beginning .
guidelines from the U.S. Department of Health and Human Services currently recommend efavirenz or a protease inhibitor, in combination with tenofovir and emtricitabine, as a preferred drug regimen for adults beginning antiretroviral treatment. Efavirenz, tenofovir and emtricitabine make up a once-a-day combination (atripla) approved by the FDA in 2006. The authors note that raltegravir is usually taken twice a day, which may be more difficult for some patients. ...